[HTML][HTML] Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies
A Nombel, N Fabien, F Coutant - Frontiers in immunology, 2021 - frontiersin.org
Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in
Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly …
Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly …
Haemophagocytic syndrome and COVID-19
S Retamozo, P Brito-Zerón, A Sisó-Almirall… - Clinical …, 2021 - Springer
Primary and secondary haemophagocytic lymphohistiocytosis (HLH) are hyperferritinaemic
hyperinflammatory syndromes with a common terminal pathway triggered by different …
hyperinflammatory syndromes with a common terminal pathway triggered by different …
[HTML][HTML] Постковидные неврологические синдромы
ВВ Белопасов, ЕН Журавлева… - Клиническая …, 2021 - cyberleninka.ru
В статье освещены патогенез, клинические проявления поражения центральной и
периферической нервной системы, возникшие или сохраняющиеся у больных в …
периферической нервной системы, возникшие или сохраняющиеся у больных в …
[HTML][HTML] COVID-19 disease and dermatomyositis: a mini-review
J Qian, H Xu - Frontiers in immunology, 2022 - frontiersin.org
The pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has
caused a large number of deaths, and there is still no effective treatment. COVID-19 can …
caused a large number of deaths, and there is still no effective treatment. COVID-19 can …
Compassionate use of remdesivir in children with COVID-19
A Méndez-Echevarría, A Pérez-Martínez… - European journal of …, 2021 - Springer
Children represent a minority of total COVID-19 cases, but studies have reported severe
disease and death in pediatric patients. Remdesivir (RDV) has recently demonstrated …
disease and death in pediatric patients. Remdesivir (RDV) has recently demonstrated …
Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?
Background Pneumocystis jirovecii (P. jirovecii) is increasingly identified on lower
respiratory tract specimens of COVID-19 patients. Our narrative review aims to determine …
respiratory tract specimens of COVID-19 patients. Our narrative review aims to determine …
Epidemiology of systemic mycoses in the COVID-19 pandemic
MG Frías-De-León, R Pinto-Almazán… - Journal of Fungi, 2021 - mdpi.com
The physiopathologic characteristics of COVID-19 (high levels of inflammatory cytokines and
T-cell reduction) promote fungal colonization and infection, which can go unnoticed because …
T-cell reduction) promote fungal colonization and infection, which can go unnoticed because …
[HTML][HTML] MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
P David, S Sinha, K Iqbal, G De Marco, S Taheri… - Ebiomedicine, 2024 - thelancet.com
Summary Background Anti-MDA5 (Melanoma differentiation-associated protein-5) positive
dermatomyositis (MDA5+-DM) is characterised by rapidly progressive interstitial lung …
dermatomyositis (MDA5+-DM) is characterised by rapidly progressive interstitial lung …
[HTML][HTML] Post-covid-19 neurological syndromes
VV Belopasov, EN Zhuravleva… - Journal of Clinical …, 2021 - journals.eco-vector.com
The article highlights the pathogenesis, clinical manifestations of lesions of the central and
peripheral nervous system that have arisen or persist in patients in the postcoid period …
peripheral nervous system that have arisen or persist in patients in the postcoid period …
The significance of autoantibodies in juvenile dermatomyositis
D Kwiatkowska, A Reich - Biomed Research International, 2021 - Wiley Online Library
Juvenile dermatomyositis is a chronic and rare autoimmune disorder classified into the
spectrum of idiopathic inflammatory myopathies. Although this entity is mainly characterized …
spectrum of idiopathic inflammatory myopathies. Although this entity is mainly characterized …